Fundraising Strategies

To help craft crucial documents required for your next fundraising round, we prepared financing guides, such as how to structure your investor deck, dataroom, 1-pager how-to's and much more.

Investor Deck

Investor Deck Checklist

This checklist contains all recommended slides for an Investor Presentation along with their conventional ordering.

Investor Deck: Supporting Slides

The supporting slides illustrate some of the slide content suggested in the investor deck checklist and contain various market segmentation and Gantt chart templates for your use.


1. Investor Pitch (Peter Adams):

Offers basic pitch guidance based on know your audience, convey value while being personal and authentic and getting the next meeting with an investor (December 1, 2015)

2. Presentation Skills (Nick Kuryluk; Lisa Sorge)

Delivers practical advice and a pragmatic plan to improve presentation skills, particularly to a US VC audience. (January 19, 2018)

Provides an overview of key materials for your fundraise (June 26, 2018)

Links and resources for pitch decks and beyond:

NextView Ventures

“You need two decks”: (1) a short deck with kitchen-sink FAQs to be used in a conversation, and (2) a “show” deck to be used if presenting in front of crowds as in a demo-day scenario or when presenting to a larger group of VC partners. 


Arthur Boni

How to create an investor/partnership focused deck. (BIO 2017, San Diego)


Don’t Pitch A Venture Capitalist Without This Checklist

A brief checklist of items to identify prior to a Venture Capital pitch.  (Courtesy of David Teten) (February 11, 2015)


Document Checklist

Must-have documents to include in your data room.

Ela Borenstein, Managing Partner, BDC Capital Healthcare Venture Fund; Ihor Boszko, Vice President, Business Development, Xagenic

How to best prepare for the due diligence process. Covers topics such as: the creation of a Data Room; what investors are looking for; and common mistakes and tips in the due diligence process. (March 22, 2016)

Fundraising from Venture Capitalists and Angels

Various webinars and articles on the difference between fundraising from Venture Capitalists, Angels and Strategics are featured below:

Startup Fundraising 101: The Pros and Cons of Angels, VCs, Angel Groups, and Syndicates

This article demonstrates the difference between funding from various sources. (January 7, 2018)

Talking to Investors & Strategics

Presented a workshop on dealing with strategic partners and Venture Capitalists, in addition to a crash course on using Pitchbook (November 21, 2018)

Kelly Holman, Genesys Capital

Provides unique and valuable insights on the financing landscape for health science companies in Ontario. Addresses the essentials for raising capital and perspectives on what specific opportunities investors look for. (February 26, 2016)

View Behind Venture Capital

This article demonstrates the systematic approach to identify and prioritize potential investors. (January 2014)

Aligning Needs

An article which discusses the importance of understanding what investors and partners want from an entrepreneur. (March 10, 2018)

Twenty Questions VC’s May Ask

This article contains and elaborates on questions from Venture Capitalists (Courtesy of VentureLab) (2009)

Deal Questions VCs Will Ask You When Fundraising

Addresses many of the key deal-related questions that are likely to come up when talking to VCs.

Financial Questions VCs Will Ask You When Fundraising

Addresses many of the finance-related questions that a VC may ask.

Company Evaluation Sheet

This document is used by Venture Capitalists while evaluating a company. (Courtesy of Skyler Fernandes)

Best Practice Guidance for Angel Groups – Deal Structure and Negotiation

An article which provides a summary of angel investor deal structure (Courtesy of the Angel Capital Education Foundation)

Neil Klompas, Chief Financial Officer, Zymeworks

Lessons learned on attracting Angel investors, the importance of investor relations for private bioscience companies and key insights into corporate structures and securities pitfalls. (August 19, 2014)

Attracting Angels

Henry Kay, Boston Harbor Angels; Mark Kohler, Exelerate Capital

The Who, What, Why, & Where of Angel Investors.  Pitching to angels, structure, regulations & VC’s, valuations & statistics, investor relations and trends. (October 18, 2016)

Grant Blevins, FCA Venture Partners

Addresses key questions Digital Health Companies ask as they raise funds such as:  what is the optimal size of the raise; justifying your ask and what are your value creation milestones? (July 11, 2017)

Digital Health Experts Q&A

A workshop on the financing landscape of the digital health industry. FCA Venture Partners provides early stage capital for innovative digital health companies focusing on B2B SaaS. (May 12, 2017)

Investor Targeting & Outreach

The section contains tools and materials on building an investor target list. A good place to start your search for investors is in PitchBook – key information on this database can be found in the Database & Conference portal on the OBIO Member Resources webpage.

Investor Contact Tracker

An excel file to track basic interactions with investors.

Christine Charette, OBIO

How to data mine a prospectus, utilize free vs. paid databases, use keywords & news sources, garner market intelligence using social media platforms. (November 3, 2016)

How to Cold Email an Investor

An article which provides insight on nine key factors to create a targeted list of investors.

How do I Create a Targeted List of Investors?

An article which provides insight on nine key factors to create a targeted list of investors.

Networking on Steroids: Using CB Insights to Build Investor Contacts at Scale

This article discusses strategies for investor outreach.

Venturing Across the Atlantic

An article which elaborates on finding investors overseas.

In Search of Dry Powder

The article provides a summary of VC firms which are investing in life science companies as of 2013. 

The supplemental material contains a list of VC firms who invest in life sciences as of 2013.

Website Design for Investors

Dennis Ford’s Fundraising Manifesto

Chapter 7 (page 87) of Dennis Ford’s Fundraising Manifesto provides the key considerations for creating an investor-geared website.

Introduction to Digital Marketing

Bernie Schmidt, Profitable Conversions

a.       Information on website design, page flow, site navigation and content (June 12, 2018)

Elevator Pitch

2 Minute Pitch Considerations

This list provides the main considerations while structuring a two-minute pitch.

Executive Summary Templates

Template 1

A brief outline of what to include in your company one-pager

Template 2

A brief outline of what to include in your company one-pager

1-Pager Advice

A guide on what to include in your one-pager


Dilution and Valuation Calculator

This dilution and valuation calculator provides key valuation information from exit, percent ownership and post-money valuation inputs.

Richard Meadows, Bioinnovation Capital Fund and Andy Haigh, Adapsyn

How VCs think about valuation and how valuation is translated into deal structure. Andy Haigh provided a demonstration of his proprietary modelling engine. Both speakers addressed ROI needed for investors, valuation methods commonly used, criteria for selecting comparable companies, characteristics of equity and debenture instruments, consequences of dilution and follow-on investment, calculating exit payouts and red flags and how to prepare to discuss valuation with investors. (June 25, 2018)

Value your Venture

James Rowland, Bloom Burton

Types of valuation methods used for early stage companies, the need to remain flexible with valuations as the market will determine it, realistic ranges of valuations to expect at a seed round.  (October 12, 2016)

Gregory Phipps, Managing Director, Innovacorp

The top five valuation methods for early-stage bioscience companies seeking financing. (November 17, 2014)

Non-Dilutive Funding List

Non-Dilutive Funding List

OBIO has assembled a list of more than $50 million in cash funding through 100+ non-dilutive grants, pitch competitions, incubator applications and investment programs.  This is an excellent tool to get you started on building a funding strategy that includes a strong non-dilutive component.

Developing a Non-Dilutive Funding Strategy

David Cayea, COO Plantform

Discusses how Plantform has raised over $6.5M in non dilutive funding. (June 26, 2018)

NIH Funding

David Hood

How can Canadian companies access US National Institutes of Health (NIH) Funding to advance their medical research and development. David also showed the various pathways for Canadian companies to access this funding. (March 5, 2018)

Meet the Non-Dilutive Money! (2) 

Brad Brinton, Ontario Centres for Excellence; Laurent Moreno, AGE-WELL, Shobha Ramsubir, Ontario Genomics, Paul McVeigh, IRAP

Speakers explained who their organizations are, their mandates, and how companies can optimize their opportunity to secure non-dilutive funding through their respective funding programs. (October 27, 2017)

Meet the Non-Dilutive Money! (1)

This event featured representatives from OCE, NSERC, NRC-IRAP, Mitacs and OBI each presented their mandate and funding programs. (February 23, 2017)

Make the most of your Application: SR&ED Tax Credits and Refunds

Kevin Fernandes, SRED Solutions

The mechanics of SRED: what is SR&ED, how to qualify, tips and common pitfalls for 1st time filers, what is SR&ED financing, review of a health tech case study and filing timelines. (September 26, 2017)

CQDM Non-Dilutive Funding Opportunities

Steve Xanthoudakis

An in-depth view of the non-dilutive funding programs offered by CQDM which have supported several Ontario health science companies. Topics covered included: Quantum Leap & SynergicQc programs, application & funding process and mentorship & large pharma partners. (May 1, 2018)

Strategic Partnerships

How To Write a Partnering Message

This article contains the structure and key ideas of a typical partnership outreach email, courtesy of Life Science Nation.

McCammon 2014 Nat. Biotech

This article elaborates on the key concepts on raising money from Corporate VC’s.This article elaborates on the key concepts on raising money from Corporate VC’s.

Alexion Pharmaceutical - Best Practices for Approaching Strategic

Andrew Hutchinson, Alexion Pharma

The difference between an investor deck and a partnering deck. The two have a very different purpose (and audience), and thus should be structured differently. (October 2, 2017)

BIO 2017: SME-MNE Partnering Preparation Workshop

Andrew Murdin, OBIO

OBIO partnered with the National Research Council Canada’s Industrial Research Assistance Program (NRC-IRAP) to present a Partnering Preparation Workshop to provide Small and Medium Enterprises (SMEs) in the biotechnology community, with in-depth insight into partnering with a Multinational Enterprise (MNE). (April 13, 2017)

Fundraising Literature

The Life Science Executive’s Fundraising Manifesto

Dennis Ford, CEO of Life Science Nation

A book on best practices for identifying capital in the biotech and medtech arenas.

The A-Z of Fundraising

Excerpts from the Private Debt Investor’s guide to navigate the fundraising landscape.

Metrick & Yasuda 2011 - Venture Capital and Finance of Innovation

An excellent book authored by Metrick & Yasuda on understanding how VC’s work, make money, and beyond.